Raymond Anderson, Director at Monopar Therapeutics (MNPR), sold 3,142 shares at $110.04 ($351K) on 2026-08-25, disclosed to the SEC on 2026-08-27.
Scheduled sale ($351k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.04 | 694 | $76K | 21.7% |
| 2 | $110.07 | 646 | $71K | 20.2% |
| 3 | $113.05 | 1,802 | $204K | 58.0% |
| Total | $111.77 avg | 3,142 | $351K | 100% |
| Filing → |
| RPTP | SELL | 2015-09-02 | $101K | — | Filing → |
| RPTP | SELL | 2015-03-26 | $259K | — | Filing → |
| RPTP | SELL | 2015-01-14 | $106K | — | Filing → |